N.A. & Europe Varicose Vein Treatment Market to See 6.9% CAGR to 2021

17 May, 2016, 06:00 ET from ReportsnReports

PUNE, India, May 17, 2016 /PRNewswire/ --

The growth of the varicose vein treatment market to 2021 in North America and Europe is majorly driven by improving patient compliance & reliability, huge burden of varicose vein cases in North America and Europe and availability of a number of treatment devices, According to the latest research.

Complete report on varicose vein treatment market in North America & Europe spread across 149 pages, profiling 5 companies and supported with 67 tables and 19 figures is now available at http://www.reportsnreports.com/reports/542837-varicose-vein-treatment-market-in-north-america-and-europe-by-treatment-mode-endovenous-ablation-sclerotherapy-stripping-products-laser-rf-ablation-venous-closure-surgical-forecasts-to-2021.html .

The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 million by 2021 from USD 207.9 million in 2016, at a CAGR of 6.9% between 2016 and 2021. North America is expected to hold the largest share of the varicose vein treatment market in 2016. The varicose vein treatment market is broadly segmented into mode of treatment and products. By products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radio frequency ablation devices and laser ablation devices. In 2016, the radio frequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.

Geographically, the report covers two major geographies, namely, North America and Europe.  In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.

Market growth is majorly driven by the shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.

The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.), among others. Order a copy of Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021 research report at http://www.reportsnreports.com/purchase.aspx?name=542837 .

As of 2015, the varicose vein treatment market was dominated by Medtronic plc (Ireland); Angio Dynamics, Inc. (U.S.); and biolitec AG (Austria) which together held a share of over 85% of the varicose vein treatment market. New product launches, strategic acquisitions, and agreements are the major strategies adopted by most market players to achieve growth in the varicose vein treatment market.

On a related note, another research on Fertility Testing Devices Market Global Forecast to 2020 says, the global fertility testing devices market is poised to grow at a CAGR of 7.5% during the forecast period and expected to reach a value of USD 216.8 Million by 2020. The ovulation prediction kits market held the larger market share. North America commanded the largest share of the global fertility testing devices market. Companies like SPD Swiss Precision Diagnostics GmbH, Church & Dwight Co., Inc., Fairhaven Health, LLC and Fertility Focus Limited are the major payer of the market and have been profile in this 122 pages research report available at http://www.reportsnreports.com/reports/525045-fertility-testing-devices-market-product-ovulation-prediction-kit-fertility-monitor-urine-based-saliva-based-basal-body-temperature-mode-of-purchase-prescription-otc-and-region-global-forecast-to-2020.html .

Explore more reports on the Pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect With Us on:

Facebook:  https://www.facebook.com/ReportsnReports/

LinkedIn:  https://www.linkedin.com/company/reportsnreports

Twitter:  https: //twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

SOURCE ReportsnReports